rs199537542

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001329943.3(KIAA0586):​c.3003C>A​(p.Asn1001Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00025 in 1,599,838 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00026 ( 1 hom. )

Consequence

KIAA0586
NM_001329943.3 missense

Scores

7
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 0.331

Publications

3 publications found
Variant links:
Genes affected
KIAA0586 (HGNC:19960): (KIAA0586) This gene encodes a conserved centrosomal protein that functions in ciliogenesis and responds to hedgehog signaling. Mutations in this gene causes Joubert syndrome 23. Alternative splicing results in multiple transcript variants and protein isoforms. [provided by RefSeq, Aug 2016]
KIAA0586 Gene-Disease associations (from GenCC):
  • Joubert syndrome 23
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • short-rib thoracic dysplasia 14 with polydactyly
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with Jeune asphyxiating thoracic dystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.26135385).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIAA0586NM_001329943.3 linkc.3003C>A p.Asn1001Lys missense_variant Exon 21 of 31 ENST00000652326.2 NP_001316872.1 A0A494C171

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIAA0586ENST00000652326.2 linkc.3003C>A p.Asn1001Lys missense_variant Exon 21 of 31 NM_001329943.3 ENSP00000498929.1 A0A494C171

Frequencies

GnomAD3 genomes
AF:
0.000184
AC:
28
AN:
151816
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000726
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000162
AC:
39
AN:
241288
AF XY:
0.000160
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000154
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000308
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000257
AC:
372
AN:
1448022
Hom.:
1
Cov.:
32
AF XY:
0.000235
AC XY:
169
AN XY:
719998
show subpopulations
African (AFR)
AF:
0.0000304
AC:
1
AN:
32860
American (AMR)
AF:
0.000161
AC:
7
AN:
43578
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25816
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38808
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84240
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53066
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5710
European-Non Finnish (NFE)
AF:
0.000315
AC:
348
AN:
1104298
Other (OTH)
AF:
0.000268
AC:
16
AN:
59646
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000184
AC:
28
AN:
151816
Hom.:
0
Cov.:
31
AF XY:
0.000135
AC XY:
10
AN XY:
74114
show subpopulations
African (AFR)
AF:
0.0000726
AC:
3
AN:
41306
American (AMR)
AF:
0.0000656
AC:
1
AN:
15236
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10488
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
67996
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.521
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000255
Hom.:
0
Bravo
AF:
0.000185
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000486
AC:
4
ExAC
AF:
0.000124
AC:
15

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Joubert syndrome 23;C4225286:Short-rib thoracic dysplasia 14 with polydactyly Uncertain:2
Jan 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 1054 of the KIAA0586 protein (p.Asn1054Lys). This variant is present in population databases (rs199537542, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with KIAA0586-related conditions. ClinVar contains an entry for this variant (Variation ID: 542185). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KIAA0586 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Sep 21, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1Benign:1
Feb 25, 2021
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Oct 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KIAA0586: BP4 -

not specified Uncertain:1
Feb 21, 2020
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DNA sequence analysis of the KIAA0586 gene demonstrated a sequence change, c.3162C>A, in exon 23 that results in an amino acid change, p.Asn1054Lys. This sequence change does not appear to have been previously described in patients with KIAA0586-related disorders and has been described in the gnomAD database with a low population frequency of 0.030% in non-Finnish European subpopulation (dbSNP rs199537542). The p.Asn1054Lys change affects a moderately conserved amino acid residue located in a domain of the KIAA0586 protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Asn1054Lys substitution. Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Asn1054Lys change remains unknown at this time. -

Inborn genetic diseases Uncertain:1
Nov 25, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2775C>A (p.N925K) alteration is located in exon 20 (coding exon 20) of the KIAA0586 gene. This alteration results from a C to A substitution at nucleotide position 2775, causing the asparagine (N) at amino acid position 925 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.48
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Benign
0.14
.;.;T;T;.;.
Eigen
Benign
-0.11
Eigen_PC
Benign
-0.15
FATHMM_MKL
Benign
0.68
D
LIST_S2
Uncertain
0.89
D;D;D;D;.;D
M_CAP
Benign
0.039
D
MetaRNN
Benign
0.26
T;T;T;T;T;T
MetaSVM
Benign
-0.63
T
MutationAssessor
Uncertain
2.4
.;.;.;M;.;.
PhyloP100
0.33
PrimateAI
Benign
0.42
T
PROVEAN
Uncertain
-4.2
D;.;.;.;D;D
REVEL
Benign
0.15
Sift
Uncertain
0.0050
D;.;.;.;D;D
Sift4G
Uncertain
0.023
D;D;D;D;D;D
Polyphen
0.93
.;.;.;P;.;.
Vest4
0.56
MutPred
0.47
.;.;.;Gain of catalytic residue at N986 (P = 0);.;.;
MVP
0.38
MPC
0.059
ClinPred
0.33
T
GERP RS
-0.23
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.30
gMVP
0.20
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199537542; hg19: chr14-58949289; COSMIC: COSV106093962; API